Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Saved in:
| Title: | Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics. |
|---|---|
| Authors: | Salkeld J; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Barrett JR; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Mitton CH; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Rawlinson TA; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Payne RO; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Hou MM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Khozoee B; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Nielsen CM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Sandoval DM; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Bach FA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Nahrendorf W; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Ramon RL; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Baker M; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ramos-Lopez F; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ellis KJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Poulton ID; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Lawrie AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Cho JS; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Nugent FL; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Spence PJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom., Silk SE; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Minassian AM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Aug 22; Vol. 13, pp. 984323. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022). |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
